A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : PBMs

Search Conditions:
Search Keyword : PBMs
Search Method : Exact match.
Research Area:

Abbreviation: PBMs
Appearance Frequency: 218 time(s)
Long forms: 29

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
peripheral blood monocytes
(100 times)
Allergy and Immunology
(18 times)
LPS (8 times)
AMs (5 times)
NK (5 times)
1983 Effect of factors other than pathologic status on responsiveness of peripheral blood mononuclear cells from patients with chronic periodontitis.
pharmacy benefit managers
(35 times)
Health Services
(8 times)
DDIs (2 times)
MCOs (2 times)
OTC (2 times)
1995 A successful field-based pharmacy program.
protein binding microarrays
(31 times)
(9 times)
TFs (9 times)
TF (4 times)
5hmC (3 times)
2004 Rapid analysis of the DNA-binding specificities of transcription factors with DNA microarrays.
pharmacy benefit management companies
(10 times)
(5 times)
CE (1 time)
FDA (1 time)
MSB (1 time)
1995 Pharmacy benefit management companies.
performance-based measures
(6 times)
(2 times)
PROs (2 times)
TUG (2 times)
2MW (1 time)
2007 Functional recovery after hip fracture in the subacute setting.
preference-based measures
(6 times)
(3 times)
HRQoL (2 times)
CS-PBMs (1 time)
DMD (1 time)
2009 Developing a descriptive system for a new preference-based measure of health-related quality of life for children.
PDZ-binding motifs
(4 times)
(3 times)
MAST2 (2 times)
AUC (1 time)
CASK (1 time)
2012 Two PDZ binding motifs within NS5 have roles in Tick-borne encephalitis virus replication.
Protein binding microarrays
(3 times)
Molecular Biology
(2 times)
ChIP-seq (1 time)
HNF4alpha (1 time)
HT (1 time)
2006 Protein binding microarrays (PBMs) for rapid, high-throughput characterization of the sequence specificities of DNA binding proteins.
PDZ-domain binding motifs
(2 times)
(1 time)
PDZ (2 times)
PPIs (1 time)
SjScrib (1 time)
2014 Characterization of diverse internal binding specificities of PDZ domains by yeast two-hybrid screening of a special peptide library.
10  population balance models
(2 times)
(1 time)
--- 2014 Population balance modelling and multi-stage optimal control of a pulsed spray fluidized bed granulation.
11  PAMP-binding molecules
(1 time)
Allergy and Immunology
(1 time)
PSMs (1 time)
2010 Endogenous ligands of TLR2 and TLR4: agonists or assistants?
12  Pancreaticobiliary maljunctions
(1 time)
General Surgery
(1 time)
BDC (1 time)
2017 Pancreaticobiliary Maljunctions in European Patients with Bile Duct Cysts: Results of the Multicenter Study of the French Surgical Association (AFC).
13  Paternal biocontainment methods
(1 time)
(1 time)
GM (1 time)
2015 Assessing the value of imperfect biocontainment nationally: rapeseed in the United Kingdom as an exemplar.
14  pattern-based methods
(1 time)
(1 time)
EBMs (1 time)
TBMs (1 time)
2006 Phylogenetic tests of distribution patterns in South Asia: towards an integrative approach.
15  peripheral blood derived macrophages
(1 time)
Allergy and Immunology
(1 time)
CRP (1 time)
IL (1 time)
2002 C-reactive protein-mediated phagocytosis of Leishmania donovani promastigotes does not alter parasite survival or macrophage responses.
16  peripheral blood macrophages
(1 time)
(1 time)
HTLV-I (1 time)
IL-1 beta (1 time)
RT-PCR (1 time)
1994 Extracellular human T-cell lymphotropic virus type I Tax protein induces cytokine production in adult human microglial cells.
17  peripheral blood mononuclear white blood cells
(1 time)
(1 time)
--- 1984 Measurement of ferritin-bearing peripheral mononuclear blood cells in cancer patients by radioimmunoassay.
18  peripheral blood-derived monocytes-macrophages
(1 time)
Communicable Diseases
(1 time)
AMs (1 time)
IAV (1 time)
2016 Human Alveolar Macrophages May Not Be Susceptible to Direct Infection by a Human Influenza Virus.
19  Pharmaceutical benefit managers
(1 time)
(1 time)
--- 2018 The relationship between pharmacy benefit managers (PBMs) and the cost of therapies in the US pharmaceutical market: A policy primer for clinicians.
20  phenanthrene-butadiynylene macrocycles
(1 time)
(1 time)
COR (1 time)
DFT (1 time)
STM (1 time)
2016 A size, shape and concentration controlled self-assembling structure with host-guest recognition at the liquid-solid interface studied by STM.
21  phosphate binder medications
(1 time)
(1 time)
--- 2016 Phosphate binder choices used in ESRD patients.
22  Physiologically based models
(1 time)
(1 time)
--- 1994 The use of physiologically based models to simulate enantioselective differences in pharmacokinetics.
23  plant bioclimatic models
(1 time)
--- 2015 Plant bioclimatic models in climate change research.
24  polymer-based materials
(1 time)
Environmental Health
(1 time)
--- 2014 Occurrence, degradation, and effect of polymer-based materials in the environment.
25  predictive behavioral markers
(1 time)
Behavioral Sciences
(1 time)
ASIB (1 time)
PBioMs (1 time)
2018 Identifying predictive behavioral markers: A demonstration using automatically reinforced self-injurious behavior.
26  process-based manipulations
(1 time)
(1 time)
AOS (1 time)
COCs (1 time)
NAs (1 time)
2017 A risk-based approach for identifying constituents of concern in oil sands process-affected water from the Athabasca Oil Sands region.
27  protein binding membranes
(1 time)
(1 time)
fHIA (1 time)
2009 Surveillance of Fungal Allergic Sensitization Using the Fluorescent Halogen Immunoassay.
28  Protein-body membranes
(1 time)
(1 time)
ER (1 time)
1984 Synthesis of an integral protein of the protein-body membrane in Phaseolus vulgaris cotyledons.
29  purified bovine mononuclear cells
(1 time)
(1 time)
CMV (1 time)
EGFP (1 time)
TamS1 (1 time)
2001 Transient transfection of Theileria annulata.